Citation Tools

Download PDFPDF

235 Preclinical evaluation and anti-tumor activity of AZD6422, a CLDN18.2 targeting armored CAR-T for gastric, esophageal and pancreatic cancers

Download to a citation manager

Cite this article as:
Britton Z, Breen S, Carrasco R, et al
235 Preclinical evaluation and anti-tumor activity of AZD6422, a CLDN18.2 targeting armored CAR-T for gastric, esophageal and pancreatic cancers